000 02351cam a22003858i 4500
001 21509697
003 OSt
005 20260227104955.0
008 200423s2020 flu b 001 0 eng
010 _a 2020009451
020 _a9780367024673
_q(hardback)
020 _z9780429399299
_q(ebook)
035 _a21509697
040 _aKABLIB
_beng
_eKABLIB
_cKABLIB
042 _apcc
050 0 0 _aRS380
_b.E94 2020
082 0 0 _a615.19
_223
_bEVE
100 1 _aEvens, Ronald P.,
_eauthor.
_915554
245 1 0 _aBiotechnology :
_bthe science, the products, the government, the business /
_cby Ronald P. Evens.
250 _aFirst edition.
263 _a2006
264 1 _aBoca Raton, FL :
_bCRC Press,
_c2020.
300 _axix, 182p. :
_bill ;
_c25 cm
336 _atext
_btxt
_2rdacontent
337 _aunmediated
_bn
_2rdamedia
338 _avolume
_bnc
_2rdacarrier
490 0 _aDrugs and the pharmaceutical sciences
504 _aIncludes bibliographical references and index.
520 _a"The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features comprehensive coverage of biotechnology science topics used in development and manufacturing, addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline, presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved"--
_cProvided by publisher.
650 0 _aPharmaceutical biotechnology.
_915555
650 0 _aPharmaceutical biotechnology industry.
_915556
906 _a7
_bcbc
_corignew
_d1
_eecip
_f20
_gy-gencatlg
942 _2ddc
_cBOOK
999 _c6121
_d6121